补充C1q和·维勒布兰德因子相互作用在人类大脑动脉动脉样硬化中的作用
Kristina Schulz1,2, Claudia Donat1, Mukesh Punjabi3
1Laboratory of Clinical Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland.
Frontiers in immunology
|December 29, 2023
概括
研究人员在人体动脉中发现了C1q-von Willebrand Factor (vWF) 复合体,表明它们在健康组织中最为丰富,并且随着动脉样硬化而减少. 这些复杂物还与动脉表面的胆固醇晶体相互作用.
科学领域:
- 心血管生物学 心血管生物学
- 免疫学 免疫学 免疫学
- 血管医学 血管医学
背景情况:
- 动脉样硬化是一种炎症性血管疾病,其特点是胆固醇晶体沉积.
- 关于胆固醇晶体上的补充激活和血液静止之间的相互作用,存在有限的体外数据.
研究的目的:
- 为了证明C1q-von Willebrand Factor (vWF) 复合体在人类动脉样硬化动脉中的存在和局部化.
- 调查C1q和vWF与动脉样硬化变化和胆固醇晶体相关的同定位.
主要方法:
- 免疫光染和近距离结合试验 (PLA) 用于人类大脑动脉截面.
- 分析包括健康的动脉,动脉样硬化动脉和血栓动脉切除术材料.
主要成果:
- 与患病组织相比,在健康组织中观察到C1q和vWF的水平显著更高.
- 通过PLA在健康样本中发现了C1q和vWF的更大的同定位.
- 在患病样本中,信号在动脉瘤和泡细胞区域是最高的,在胆固醇晶体上减少但存在的同定位.
结论:
- C1q-vWF复合体在人体动脉中存在活体.
- 这些复合体在健康的内皮和子内皮空间中最为丰富.
- C1q-vWF相互作用发生在胆固醇晶体表面上,这表明它在动脉样硬化病变发生过程中发挥了作用.
更多相关视频
11:00A Model of Disturbed Flow-Induced Atherosclerosis in Mouse Carotid Artery by Partial Ligation and a Simple Method of RNA Isolation from Carotid Endothelium
Published on: June 22, 2010
28.6K
07:51Implantation of a Carotid Cuff for Triggering Shear-stress Induced Atherosclerosis in Mice
Published on: January 13, 2012
20.2K
相关概念视频
01:22Formation of the Platelet Plug
6.3K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.3K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
702
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
702
01:16Clot Retraction and Fibrinolysis
6.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.0K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
7.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.8K